Rxivist logo

Author: Nicholas Kitchin

  • Most recently observed institution: Vaccine Research and Development, Pfizer, Inc.

Rankings

  • All-time downloads: 141,990 (rank: 622 (tie) )
  • Categories:
    • infectious diseases: 141,990 (rank: 152 (tie) )

Downloads per author, site-wide

Preprints

RNA-Based COVID-19 Vaccine BNT162b2 Selected for a Pivotal Efficacy Study

infectious diseases more details view paper
  • Downloaded 72,083 times
  • Download rankings, all-time:
    • Site-wide: 79
    • In infectious diseases: 30
  • Year to date:
    • Site-wide: 73
  • Since beginning of last month:
    • Site-wide: 79

Phase 1/2 Study to Describe the Safety and Immunogenicity of a COVID-19 RNA Vaccine Candidate (BNT162b1) in Adults 18 to 55 Years of Age: Interim Report

infectious diseases more details view paper
  • Downloaded 69,907 times
  • Download rankings, all-time:
    • Site-wide: 82
    • In infectious diseases: 31
  • Year to date:
    • Site-wide: 258
  • Since beginning of last month:
    • Site-wide: 351

PanLingua

News